• Pilot trial assesses sensory stimulation as a treatment for improving mobility in stroke survivors

    10 days ago - By News Medical

    Keele University researchers have completed the first phase of trials for treatments which aim to improve outcomes for stroke survivors that are learning to walk again.
    Read more ...

     

  • Q&A: Phase 1b trial will assess oral-administered vascular adhesion protein-1 inhibitor for NASH

    Q&A: Phase 1b trial will assess oral-administered vascular adhesion protein-1 inhibitor for NASH

    10 days ago - By Healio

    Terns Pharmaceuticals Inc. announced initiation of a phase 1b clinical trial assessing TERN-201 for the treatment of patients with nonalcoholic steatohepatitis.
    According to a press release, TERN-201 is an orally administered inhibitor of vascular adhesion protein-1. The AVIATION trial is a multi-center, randomized, double-blind, dose-ranging, placebo-controlled, phase 1b clinical study of the safety, pharmacokinetics, pharmacodynamics and efficacy of TERN-201 in patients with presumed non-cirrhotic NASH and a cT1 value of greater than 800ms. Researchers will compare the safety and
    Read more ...